Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled StudyNCT07001800KARDPhase 2, Phase 3Recruiting2028-08-31Estimated
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AMLNCT07007312KURAPhase 3Recruiting2031-11Estimated
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast CancerNCT07007559ALX Oncology Inc.Phase 2Recruiting2027-12Estimated
A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis SuppurativaNCT07007637MoonLake Immunotherapeutics AGPhase 3Enrolling by invitation2028-06-13Estimated
RESTORE TRIAL: Study of the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)NCT07009860ALTPhase 2Active not recruiting2027-09-30Estimated
Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387NCT07010159KNSAPhase 2, Phase 3Recruiting2027-12-31Estimated
A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of RelutrigineNCT07010471Praxis Precision MedicinesPhase 3Active not recruiting2026-12Estimated
ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic DermatitisNCT07011706ACRSPhase 2Active not recruiting2026-08Estimated
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell CarcinomaNCT07011719RCUSPhase 3Recruiting2028-04Estimated
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative ColitisNCT07012395SYREPhase 2Recruiting2027-06Estimated
Neoadjuvant Darovasertib in Primary Uveal MelanomaNCT07015190IDEAYA BiosciencesPhase 3Recruiting2030-10Estimated
A Recovery and Lifespan Study Using INTERCEPT Red Blood Cells Prepared Using the INTERCEPT Blood System for RBCs With AS-1NCT07015437Cerus CorporationPhase 2Recruiting2026-12-15Estimated
A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis BullosaNCT07016750KRYSPhase 3Recruiting2026-12Estimated
A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and SafetyNCT07019922Praxis Precision MedicinesPhase 3Recruiting2026-12Estimated
An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (FORWARD Study)NCT07020819ANNXPhase 3Recruiting2026-12-31Estimated
Monthly Dosing of Atacicept in IgANNCT07020923VERAPhase 2Active not recruiting2026-09Estimated
DT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal DystrophyNCT07024693DSGNPhase 2Recruiting2027-12Estimated
Study to Evaluate Efficacy and Dose Response of Imapextide (STEADI)NCT07029412MBX BiosciencesPhase 2Completed2026-04-18Actual
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia PsychosisNCT07029581ACADPhase 2Recruiting2028-02Estimated
C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCVNCT07037277AVIRPhase 3Active not recruiting2026-12Estimated
A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)NCT07037771Arrowhead PharmaceuticalsPhase 3Active not recruiting2027-08-20Estimated
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With SchizophreniaNCT07038876MapLight TherapeuticsPhase 2Completed2026-06-04Actual
FMXIN002 in Patients at Risk of AnaphylaxisNCT07045701Nasus PharmaPhase 2, Phase 3Enrolling by invitation2026-06-12Estimated
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I DisorderNCT07046494RAPPPhase 2Active not recruiting2026-08-05Actual
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular AtrophyNCT07047144Scholar Rock, Inc.Phase 2Recruiting2028-11Estimated
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular DegenerationNCT070647594D Molecular TherapeuticsPhase 3Recruiting2028-11Estimated
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)NCT07065240Seaport TherapeuticsPhase 2Recruiting2027-03Estimated
Safety, Tolerability and Efficacy of Trichostatin A in Patients With Mild to Severe OnychomycosisNCT07065773Vanda PharmaceuticalsPhase 2Active not recruiting2026-09Estimated
A Study of Orelabrutinib in Patients With Primary Progressive Multiple SclerosisNCT07067463Zenas BioPharma (USA), LLCPhase 3Recruiting2030-06Estimated
Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral ImplantNCT07075718Glaukos CorporationPhase 2Recruiting2028-03Estimated

Primary completion marks the end of data collection for the main study measures, not a results publication date.